128 related articles for article (PubMed ID: 12443833)
1. Effects of hormone replacement therapy on cardiovascular responses in postmenopausal women with and without type 2 diabetes.
Manwaring P; Phoon S; Diamond T; Howes LG
Maturitas; 2002 Nov; 43(3):157-64. PubMed ID: 12443833
[TBL] [Abstract][Full Text] [Related]
2. The effects of hormone replacement therapy on plasma lipids in type II diabetes.
Manwaring P; Morfis L; Diamond T; Howes LG
Maturitas; 2000 Mar; 34(3):239-47. PubMed ID: 10717490
[TBL] [Abstract][Full Text] [Related]
3. Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women.
Hayward CS; Samaras K; Campbell L; Kelly RP
Am J Hypertens; 2001 Jul; 14(7 Pt 1):699-703. PubMed ID: 11465656
[TBL] [Abstract][Full Text] [Related]
4. Effects of hormone replacement therapy on ambulatory blood pressure and vascular responses in normotensive women.
Manwaring P; Morfis L; Diamond T; Howes LG
Blood Press; 2000; 9(1):22-7. PubMed ID: 10854004
[TBL] [Abstract][Full Text] [Related]
5. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
Ichikawa J; Sumino H; Ichikawa S; Ozaki M
Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
[TBL] [Abstract][Full Text] [Related]
6. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women.
Vongpatanasin W; Tuncel M; Mansour Y; Arbique D; Victor RG
Circulation; 2001 Jun; 103(24):2903-8. PubMed ID: 11413078
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
[TBL] [Abstract][Full Text] [Related]
8. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
[TBL] [Abstract][Full Text] [Related]
9. Effect of hormone replacement therapy on inflammation-sensitive proteins in post-menopausal women with Type 2 diabetes.
Manning PJ; Sutherland WH; Allum AR; de Jong SA; Jones SD
Diabet Med; 2002 Oct; 19(10):847-52. PubMed ID: 12358873
[TBL] [Abstract][Full Text] [Related]
10. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women.
Nogawa N; Sumino H; Ichikawa S; Kumakura H; Takayama Y; Nakamura T; Kanda T; Mizunuma H; Kurabayashi M
Menopause; 2001; 8(3):210-5. PubMed ID: 11355044
[TBL] [Abstract][Full Text] [Related]
12. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study.
Samaras K; Hayward CS; Sullivan D; Kelly RP; Campbell LV
Diabetes Care; 1999 Sep; 22(9):1401-7. PubMed ID: 10480500
[TBL] [Abstract][Full Text] [Related]
13. Effects of hormone replacement therapy on ambulatory blood pressure and vascular responses in normotensive women.
Paul Manwaring Litsa Morfis Terence Diamond Laurence G Howes
Blood Press; 2000; 9(1):22-27. PubMed ID: 28425783
[TBL] [Abstract][Full Text] [Related]
14. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin.
Sumino H; Ichikawa S; Kanda T; Sakamaki T; Nakamura T; Sato K; Kobayashi I; Nagai R
Am J Hypertens; 1999 Oct; 12(10 Pt 1):1044-7. PubMed ID: 10560792
[TBL] [Abstract][Full Text] [Related]
16. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement.
Light KC; Grewen KM; Amico JA; Brownley KA; West SG; Hinderliter AL; Girdler SS
Horm Behav; 2005 May; 47(5):540-8. PubMed ID: 15811355
[TBL] [Abstract][Full Text] [Related]
17. Oral 17beta-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size.
Tangney CC; Mosca LJ; Otvos JD; Rosenson RS
Atherosclerosis; 2001 Apr; 155(2):425-30. PubMed ID: 11254913
[TBL] [Abstract][Full Text] [Related]
18. HRT decreases DNA and lipid oxidation in postmenopausal women.
Escalante Gómez C; Quesada Mora S
Climacteric; 2013 Feb; 16(1):104-10. PubMed ID: 22530644
[TBL] [Abstract][Full Text] [Related]
19. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
Circulation; 2002 Oct; 106(14):1771-6. PubMed ID: 12356628
[TBL] [Abstract][Full Text] [Related]
20. Effects of conjugated oestrogen and droloxifene on the renin-angiotensin system, blood pressure and renal blood flow in postmenopausal women.
Seely EW; Brosnihan KB; Jeunemaitre X; Okamura K; Williams GH; Hollenberg NK; Herrington DM
Clin Endocrinol (Oxf); 2004 Mar; 60(3):315-21. PubMed ID: 15008996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
